Short Interest in MediPharm Labs Corp. (OTCMKTS:MEDIF) Decreases By 15.9%

MediPharm Labs Corp. (OTCMKTS:MEDIF) was the recipient of a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 597,100 shares, a decrease of 15.9% from the December 15th total of 710,100 shares. Based on an average trading volume of 412,200 shares, the short-interest ratio is currently 1.4 days.

MediPharm Labs Stock Performance

Shares of OTCMKTS:MEDIF opened at $0.05 on Friday. MediPharm Labs has a 52-week low of $0.04 and a 52-week high of $0.07. The business has a 50-day moving average price of $0.05 and a 200-day moving average price of $0.05.

MediPharm Labs Company Profile

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products.